The collapse in non-COVID care
While the NHS has focused on fighting coronavirus, care for non-COVID patients has dropped sharply. Will those patients come back?
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Closing the distance
Remote treatment calls for a collaborative approach
Leading the fight
Oxfordshire has a unique life sciences ecosystem which has enabled it to mobilise rapidly and lead the international response to COVID-19, says Sebastian Johnson
Safety first
Andrew Rut on why drug safety should be top of mind during COVID-19 development
A secure connection?
The doctor will see you (online) now, but so could the fraudsters
In greener shoes
Is pharma ready for the effects of the climate crisis on global health?
Amplifying the ask of patient communities
Ben Osborn, Pfizer’s UK country manager, shares his thoughts on why the Patient Partnership Index and the values it celebrates matter more now than ever before....
Young Leaders: Fliss Barber
PharmaTimes talks to some of pharma and healthcare’s most promising young leaders, already making waves in their companies and brightening the future
